|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03010231
|
Sarcoehrendin J
|
methyl 9S-hydroxy-11R,15S-diacetoxy-13E-prostenoate
|
FA 25:4;O5
|
C25H42O7
|
454.293056
|
|
LMFA03010232
|
20-hydroxy-PGE1
|
9-oxo-11R,15S,20-trihydroxy-13E-prostaenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010233
|
11-deoxyprostaglandin E2 methyl ester
|
Methyl 15S-hydroxy-5Z,13E-prostadienoate
|
FA 21:4;O2
|
C21H34O4
|
350.245711
|
|
LMFA03010234
|
11-deoxy-13,14-dihydro-15-keto-PGE2
|
15-oxo-5Z-prostenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03010235
|
5E-PGB2
|
15S-hydroxy-9-oxo-5E,8(12),13E-prostatrienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA03010236
|
(5E)-13,14-dihydro-PGB2
|
15S-hydroxy-9-oxo-5E,8(12),-prostadienoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03010237
|
13,14-dihydro-PGB2
|
15S-hydroxy-9-oxo-5Z,8(12),-prostadienoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03010238
|
13,14-dihydro-PGB2 methyl ester
|
methyl 15S-hydroxy-9-oxo-5Z,8(12),-prostadienoate
|
FA 21:4;O2
|
C21H34O4
|
350.245711
|
|
LMFA08020301
|
1-tauro-PGE2
|
N-tauro-9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoate
|
NAT 20:4;O3
|
C22H37NO7S
|
459.229075
|
|
LMFA03010239
|
15dPGJ2-GS
|
11-oxo-9-(S-glutathionyl)-5Z,12E,14E-prostatetraenoic acid
|
|
C30H45N3O9S
|
623.287653
|
|
LMFA03010240
|
19-hydroxy-prostaglandin I2
|
6,9S-epoxy-11R,15S,19-trihydroxy-5Z,13E-prostadienoic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|
|
LMFA03010242
|
Delta(12)-prostaglandin J3
|
15S-hydroxy-11-oxo-5Z,9Z,12E,17Z-prostatetraenoic acid
|
FA 20:6;O2
|
C20H28O4
|
332.198761
|
|
LMFA03010241
|
15-deoxyprostaglandin J3
|
11-oxo-5Z,9Z,12E,14E,17Z-prostatetraenoic acid
|
FA 20:7;O
|
C20H26O3
|
314.188195
|
|
LMFA08020298
|
1-tauro-dinor-PGE1
|
N-tauro-9,13-dihydroxy-7-oxo-dinorprosta-11-enoate
|
NAT 18:3;O3
|
C20H35NO7S
|
433.213425
|
|
LMFA08020299
|
1-tauro-tetranor-PGE1
|
N-tauro-9,13-dihydroxy-7-oxo-tetranorprosta-11-enoate
|
NAT 16:3;O3
|
C18H31NO7S
|
405.182125
|
|
LMFA08020300
|
1-tauro-dinor-PGE2
|
N-tauro-9,13-dihydroxy-7-oxo-dinorprosta-3Z,11E-dienoate
|
NAT 18:4;O3
|
C20H33NO7S
|
431.197775
|
|
LMFA03010243
|
Tetranor-PGAM
|
8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03010244
|
PGDM
|
9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid
|
FA 16:4;O5
|
C16H24O7
|
328.152205
|
|
LMFA03010248
|
PGD1-d4
|
9alpha,15S-dihydroxy-11-oxo-prost-13E-en-1-oic-3,3,4,4-d4 acid
|
|
C20H30D4O5
|
358.265733
|
|
LMFA03010245
|
13,14-dihydro-15-keto-tetranor Prostaglandin D2
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010246
|
13,14-dihydro-15-keto-tetranor Prostaglandin E2
|
11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010247
|
tetranor-PGJM
|
11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03010249
|
13,14-dihydro-15-keto-PGE2-d4
|
9,15-dioxo-11R-hydroxy-5Z-prostenoic 3,3,4,4-d4 acid
|
|
C20H28D4O5
|
356.250082
|
|
LMFA03010250
|
15-deoxy-delta-12,14-PGJ2-d4
|
11-oxo-prosta-5Z,9,12E,14E-tetraen-1-oic-3,3,4,4-d4 acid
|
|
C20H24D4O3
|
320.228952
|
|
LMFA03010251
|
PGB2-d4
|
9-oxo-15S-hydroxy-prosta-5Z,8(12),13E-trien-1-oic-3,3,4,4-d4 acid
|
|
C20H26D4O4
|
338.239517
|
|
LMFA03010252
|
tetranor-PGDM-d6
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic-17,17,18,18,19,19-d6 acid
|
|
C16H18D6O7
|
334.189866
|
|
LMFA03010253
|
2,3-dinor-15-epi-15-F2t-IsoP
|
9S,11R,15R-trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03010254
|
13-epi-13-F1t-PhytoP
|
9S,11R,15R-trihydroxy-2,3-dinor-13E-prostaenoic acid-cyclo[8S,12R]
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA03010257
|
PGE2-d9
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic-17,17,18,18,19,19,20,20,20-d9 acid
|
|
C20H23D9O5
|
361.281466
|
|
LMFA03010256
|
PGD2-d9
|
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic-17,17,18,18,19,19,20,20,20-d9 acid
|
|
C20H23D9O5
|
361.281466
|
|
LMFA03010255
|
13,14-dihydro-15-keto-PGD1
|
9S-hydroxy-11,15-dioxo-prostanoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03010259
|
ent-2,3-dinor-5,6-dihydro-15-F2t-IsoP
|
5-[(1R,2S,3S,5R)-3,5-dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]pentanoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA03010260
|
20-carboxy-13,14-dihydro-15-keto-tetranor PGF2beta
|
9R,11R-dihydroxy-15-oxo-2,3,4,5-tetranor-prostane-1,20-dioic acid
|
FA 16:3;O5
|
C16H26O7
|
330.167856
|
|
LMFA03010261
|
13,14-dihydro-15-keto-tetranor PGF2beta
|
9R,11R-dihydroxy-15-oxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:2;O3
|
C16H28O5
|
300.193676
|
|
LMFA03010262
|
20-carboxy-PGE1
|
9-oxo-11R,15S,20-trihydroxy-13E-prosten-1,20-dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010263
|
19-hydroxyPGE2
|
9-oxo-11R,15S,19-trihydroxy-13E-prostaenoic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|
|
LMFA03010264
|
2,3,4,5-tetranor PGF3alpha
|
9S,11S,15S trihydroxy-2,3,4,5-tetranorprosta-13,17-dienoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010266
|
5,6-dihydro-2,3-dinor-PGF3alpha
|
7R,9S,13S-trihydr-dinor-prosta- 11,15-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03010267
|
13,14-dihydro-20-hydroxy-15-oxoprostaglandin F2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prostenoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03010268
|
13,14-dihydro-20-hydroxy-15-oxo-20-carboxy-PGF2alpha
|
9S,11R,20-trihydroxy-15-oxo-5Z-prosten-1,20dioic acid
|
FA 20:4;O5
|
C20H32O7
|
384.214806
|
|
LMFA03010278
|
5,6-dihydroxy PGE1
|
9-oxo-5,6,11R,15S-tetrahydroxy-13E-prostaenoic acid
|
FA 20:3;O5
|
C20H34O7
|
386.230456
|
|
LMFA03010279
|
20-hydroxy Dinor-PGD2
|
2,3-dinor-9S,15S,20-trihydroxy-11-oxo-5Z,13E-prostadienoic acid
|
FA 18:4;O4
|
C18H28O6
|
340.188591
|
|
LMFA03010280
|
13,14-dihydro-15-keto-20-hydroxy 2,3,4,5-tetranor-PGD2
|
2,3,4,5-tetranor-9S,20-trihydroxy-11,15-dioxo-5Z-prostenoic acid
|
FA 16:3;O4
|
C16H26O6
|
314.172940
|
|
LMFA03010281
|
19-hydroxy-2,3-dinor-6-oxo-PGF1alpha
|
9S,11R,15S,19-tetrahydroxy-2,3-dinor-6-oxo-13E-prostenoic acid
|
FA 18:3;O4
|
C18H30O7
|
358.199156
|
|
LMFA03010282
|
2,3-dinor-6,19-dioxo-PGF1alpha
|
9S,11R,15S-trihydroxy-2,3-dinor-6,19-dioxo-13E-prostenoic acid
|
FA 18:4;O5
|
C18H28O7
|
356.183506
|
|
LMFA03010283
|
20-hydroxy-tetranor-PGB2
|
9-oxo-15S,20-dihydroxy-8(12),13E-2,3,4,5-tetranor-prostadiienoic acid
|
FA 16:4;O3
|
C16H24O5
|
296.162375
|
|
LMFA03010284
|
20-carboxy-tetranor-PGB2
|
9-oxo-15S-hydroxy-8(12),13E-2,3,4,5-tetranor-prostadien-1,20-dioic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03010285
|
19-hydroxy-tetranor-PGB2
|
9-oxo-15S,19-dihydroxy-8(12),13E-2,3,4,5-tetranor-prostadiienoic acid
|
FA 16:4;O3
|
C16H24O5
|
296.162375
|
|
LMFA03010286
|
2,3-dinor-PGF1alpha
|
9S,11R,15S-trihydroxy-13E-2,3-dinor-prostaenoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|